BIVI: BioVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 26.99
Enterprise Value ($M) 4.63
Book Value ($M) 18.93
Book Value / Share 0.31
Price / Book 1.43
NCAV ($M) 17.69
NCAV / Share 0.29
Price / NCAV 1.53

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -1.03
Return on Equity (ROE) -2.37

Liquidity (mrq)
Quick Ratio 2.45
Current Ratio 2.45

Balance Sheet (mrq) ($M)
Current Assets 30.54
Assets 31.77
Liabilities 12.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
06-25 13D/A Acuitas Group Holdings, LLC 44.53 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)
2023-08-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED JUNE 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SEC

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 503,618 1,283,121 39.25
2024-07-25 491,837 1,184,748 41.51
2024-07-24 373,937 957,591 39.05
2024-07-23 570,134 1,793,892 31.78
2024-07-22 387,722 846,629 45.80

(click for more detail)

Similar Companies
BFRG – Bullfrog AI Holdings, Inc. BFRI – Biofrontera Inc.
BGXX – Bright Green Corporation BMRA – Biomerica, Inc.
BNTC – Benitec Biopharma Inc.


Financial data and stock pages provided by
Fintel.io